Jennifer N. Tovar, PharmD Candidate

home / authors / jennifer-n-tovar-pharmd-candidate

Articles

AHA Statement Reviews Benefits, Risks of Alternative Therapies for Heart Failure

October 1st 2024

The AHA acknowledged that complementary and alternative medicines are widely used by heart failure patients but warned that there is limited scientific evidence to support their efficacy.

Clinical Overview: Risankizumab-rzaa for Crohn Disease

Jennifer N. Tovar, PharmD Candidate

August 29th 2022

Risankizumab-rzaa is the first and only specific IL-23 inhibitor approved to treat moderately to severely active Crohn disease in adults.

Published: October 23rd 2024 | Updated: October 24th 2024

What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders

Published: January 18th 2016 | Updated: October 18th 2024

10 Pharmacy Quotes That Will Make You Rethink the Profession

Published: September 22nd 2015 | Updated: October 14th 2024

Gabapentin Differs From Pregabalin in Several Key Ways

3d rendered illustration of the anatomy of a cancer cell | Image Credit: Sebastian Kaulitzki - stock.adobe.com

Published: April 17th 2024 | Updated: November 10th 2024

Enfortumab Vedotin With Pembrolizumab Shows Promise as First-Line Therapy For Those Ineligible for Cisplatin

Published: November 3rd 2024 | Updated: November 10th 2024

Pharmacist Involvement Within ASCO: Standards Development, Certification Programs, and the Potential for Pharmacy CE at Future ASCO Meetings

Published: November 1st 2024 | Updated: November 10th 2024

Opioid Stewardship Pharmacists: More Than Just the Opioid Police

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Jennifer N. Tovar, PharmD Candidate

Articles

Latest Updated Articles